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Available online 30 April 2013Bovinemastitis is usually caused by either Gram positive or Gram negative bacteria, reducing
the quantity and quality of milk produced. This investigation using capillary electrophoresis
and mass spectroscopy, studied peptides in milk from cows with clinical mastitis in
comparison to milk from healthy cows to identify biomarkers for mastitis. In addition, the
milk peptidome from udders infected with Gram positive Staphylococcus aureus (S. aureus) or
with Gram negative Escherichia coli (E. coli), was examined to assess differential diagnosis
between the causative agent. Comparison of the peptidome between healthy (n = 10) and
mastitic milk (n = 27) identified 154 peptides for a biomarker panel which in a model for
diagnosis ofmastitis showed 100% sensitivity and specificity. β-casein and αs1 casein provided
the majority of peptides identified in this model. The peptidome comparison of milk from
mastitis cases caused by S. aureus (n = 8) or E. coli (n = 11) revealed a biomarker panel of 47
peptides which discriminated between cause of infection with a sensitivity of 75% and a
specificity of 100%. β-casein fragments were the most common of the peptides in this model.
Peptide biomarkers of milk could be used in the diagnosis of mastitis and can discriminate
between these two bacterial causes.
Biological significance
The paper describes an innovative approach to the use of gel free proteomics to identify
the peptides that are present in milk during clinical mastitis, which is a major cause of loss
of production to dairy farmers worldwide. The use of capillary electrophoresis, liquid
chromatography and mass spectrometry has been able to identify panels of peptides which
can be used for disease diagnosis and for differential diagnosis of the causative bacteria of
the infections of the mammary gland. As well as contributing to our knowledge of theKeywords:
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90 J O U R N A L O F P R O T E O M I C S 8 5 ( 2 0 1 3 ) 8 9 – 9 8pathophysiology of bovinemastitis the results could be the basis of improved detection and
differential diagnosis of the disease.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Mastitis is an inflammatory disease of the mammary gland
parenchyma which is characterized by a range of physical and
chemical changes of milk and pathological changes in the
udder tissues [1,2]. Significant milk changes that can be
observed in bovine mastitis are the presence of clots in milk,
milk discolouration and high levels of leukocyte numbers in
affected milk which lead to a rise in somatic cell count (SCC).
Furthermore, clinical signs occur in bovine mastitis including
swelling, heat and pain in the udder. Mastitis is usually caused
by bacterial infection with major pathogens being Streptococcus
agalactiae, Staphylococcus aureus (S. aureus) and Mycoplasma bovis
as well as environmental pathogens, including Streptococcus
species (Streptococcus uberis and Streptococcus dysgalactiae) and
environmental coliforms Gram negative bacteria Escherichia coli
(E. coli), Klebsiella spp., Citrobacter spp., Enterobacter spp.,
Enterobacter faecalis and Enterobacter faecium, and other Gram
negative bacteria suchas Serratia, Pseudomonas andProteus [1,3,4].
Mastitis is one of themost prevalent diseases in dairy cows.
It is an endemic disease and is the most frequent and most
costly disease affecting dairy herds worldwide [5–7]. It affects
the quality of the milk through changes in milk composi-
tion and has marked economic consequences for the dairy
industry. The economic losses due to mastitis can be caused
by milk production losses, use of treatments, discarded milk,
veterinary services, labour, product quality, materials and
investments, diagnostics, other diseases and culling [5].
Persistent decrease inmilk production is themain detrimental
effect that contributes to the economic impact of mastitis [8]
and can be caused by both clinical and subclinical mastitis.
While identification of clinical mastitis can be achieved by
identification of the clinical signs described above, subclinical
mastitis where these signs are not evident is a more problem-
atic diagnostic task. Currently subclinical mastitis is identified
bymeasurement of SCC inmilk [9] which required submission
of sample to a laboratory for automated cell counting or
associated measures such as conductivity or lactate dehydro-
genase activity. TheCaliforniaMastitis testwhich is ameasure
of SCC by agglutination may also be applied on farm [7].
Identification of alternative biomarkers of mastitis which
could be adapted to rapid, on-farm diagnostic systems would
be a valuable tool for early detection and treatment ofmastitis.
Changes are known to take place in the milk proteome
during mastitis. Clinical mastitis causes decreases in caseins,
α-lactalbumin and β-lactoglobulin [10] and increases in serum
albumin and serotransferrin. Further studies have identi-
fied additional proteins with altered expression in milk from
dairy cows with experimental induction of mastitis [11–13].
These studies have revealed increased concentrations of
chaperonins, DNA-binding proteins, enzymes, transport
proteins and structural proteins, complement factors C3 and
C4, lactoferrin, transferrin, apolipoprotein AI, fibrinogen,
glycosylation-dependent cell adhesion molecule-1, peptido-
glycan recognition receptor protein and cyclic dodecapeptide-1.In addition proteins secreted from neutrophils and lympho-
cytes have been identified.
An investigation by Ibeagha-Awemu et al. [14] has suggested
that different pathogens have varied effects on the milk
proteome. Thus, in natural cases of the disease, the proteome
of whey from cows with mastitis caused by E. coli and S. aureus
differed substantially in comparison towhey fromhealthy cows
as revealed by one-dimensional, liquid chromatography tan-
dem MS (LC–MS/MS). A total of 73 proteins were found to
be significantly different between normal whey and whey from
quarters infected with either E. coli or S. aureus. Infection with
E. coli caused a greater change in the expression of the proteins.
A potential cause of alteration of the milk proteome in
mastitis is proteolysis of milk protein by bacterial or endog-
enous proteases. Following induction of mastitis by infusion
of lipoteichoic acid (LTA), the toxin of S. aureus, Larsen et al.
[15] identified, by 2-D gel electrophoresis, hydrolysis of β- and
αS1-caseins 6 h after infusion with the toxin. Examination of
the peptides at this and later time points, using reversed-
phase HPLC and MALDI-TOF MS/MS, detected increases in the
milk peptidome with several different peptides being charac-
terized and found to originate from αS1- and β-caseins.
The analysis of change in the peptide content of biological
fluid such as serum or urine is increasingly being used as a
means to discover biomarkers for the diagnosis and monitoring
of disease. Therehave beenanumber of studies, especiallyusing
urine, that have developed biomarkers models for a number of
different diseases using capillary electrophoresis (CE) and mass
spectrometry (MS). Those investigated so far range from renal
disorders [16,17] to cardiovascular disease [18] and diabetes [19].
Many of these biomarker profiles have been recorded in a data-
base made up from over 13,000 samples [20]. These biomarkers
are not based on a single analyte but are composed of a group or
panel of proteins/peptides. Changes in the profile or pattern can
indicate a trend toward or away from the disease state.
It is likely that changingpatterns of thepeptides ofmilk could
provide a source of biomarkers formastitis so that application of
advanced peptide biomarker detection and analysis could be a
valuable addition tool in the diagnosis of mastitis.
The aim of this investigationwas to undertake a study of the
peptidespresent inmilk fromhealthydairy cows in comparison
to milk from cows with naturally occurring clinical mastitis
to determine if peptide biomarkers in milk could be identified
for use in disease diagnosis. A second aim was to determine
if peptide biomarkers could be identified which could distin-
guish between the bacteria causing naturally occurring cases of
mastitis by analysis of samples inwhich either E. coli or S. aureus
had been identified as the pathogenic agent as a means for
differential diagnosis between bacterial cause [4].
2. Material & methods
2.1. Samples
Milk samples from naturally occurring clinical cases of mas-
titis in individual udder quarters were obtained from the Vale
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ical culture performed in their laboratory to determine the
bacterial cause of bovine mastitis. Results were confirmed
by the Bacteriology Laboratory of the Veterinary Diagnostic
Services of the School of Veterinary Medicine, University of
Glasgow. Samples were plated on to 5% sheep blood agar and
on to MacConkey agar for identification of E. coli while the
presence of Gram positive bacteria including S. aureus was
identified by API Staph and API 20 Strep tests kits (Biomerieux
UK Ltd, Basingstoke, UK). Milk samples from cases of mastitis
caused by either E. coli (n = 15) or S. aureus (n = 12) infection
were selected for further analysis. Controlmilk samples (n = 10)
from healthy cows from the School of Veterinary Medicine,
University of Glasgow farm were used in this study as compar-
ison to those clinical mastitic cases. The healthy milk samples
were confirmed by somatic cell counts being <100,000 cells/ml.
2.2. Sample preparation
Milk samples were defrosted at room temperature prior to
centrifugation at 16,000 ×g for 10 min at 4 °C to remove the
milk fat. An aliquot of 700 μl of centrifuged milk was added to
700 μl of 2 M urea, 100 mM NaCl, 10 mM NH4OH containing
0.02% SDS, as described by Albalat et al. [21]. To remove higher
molecular mass proteins the sample was ultrafiltered using
Centrisart, Sartorius (Geottingen, Germany) ultracentrifuga-
tion filter devices (20 kDa MW) at 2000 g until 1.1 ml of filtrate
was obtained. This filtrate was then applied onto a PD-10
desalting column, (GE Healthcare Biosciences, Uppsala, Sweden)
equilibrated in 0.01% NH4OH in HPLC-grade H2O to decrease
matrix effects by removing urea, electrolytes, salts, and to enrich
polypeptides present. Finally, all samples were lyophilized and
stored at 4 °C.
2.3. Protein estimation
Protein concentration in milk extracted samples was checked
using the BCA assay Uptima from Interchim (Montluçon,
France). A known amount (25 μl) of each standard and milk
extracted samples was pipetted into microplate wells in
duplicate. The BCA assay reagent was then added (200 μl)
and mixed. The sample mixtures were incubated at 37 °C for
30 min. Prior to reading the results at the optical absorbance of
562 nm, the microplate was allowed to cool to room temper-
ature. The standard curve of protein concentration, bovine
serum albumin (Sigma Aldrich, Dorset, UK) ranging from 2
up to 500 μg/ml was plotted and the protein concentration in
the sample was interpolated. Freeze-dried aliquots were re-
suspended in appropriate volume of Milli Q water to reach a
concentration of 2 μg/μl before running in the CE.
2.4. CE–MS analysis
Samples were re-suspended in HPLC-grade H2O shortly before
CE–MS analyses, as described [21]. CE–MS analysis was per-
formed using a P/ACE MDQ capillary electrophoresis system
(Beckman Coulter, Fullerton, USA) using a 90 cm 360 μm OD,
50 μm ID capillary with a tapered tip (New Objective, Woburn,
USA) on-line coupled to a micrOTOF MS (Bruker Daltonic,
Bremen, Germany) as described previously [22]. The ESI sprayer(Agilent Technologies, Palo Alto, CA, USA) was grounded,
and the ion spray interface potential was set between −4 and
−4.5 kV. Data acquisition and MS acquisition methods were
automatically controlled by the CE via contact-close-relays.
Spectra were accumulated every 3 s, over a range of m/z 350 to
3000. Accuracy, precision, selectivity, sensitivity, reproducibili-
ty, and stability of the CE–MSmeasurements were demonstrat-
ed elsewhere [16].
2.5. LC–MS/MS analysis
The milk extracts were also analysed on a Dionex Ultimate
3000 RSLS nano-flow system (Dionex, Camberly UK). The
samples (5 μl) were loaded onto a Dionex 100 μm × 2 cm
5 μm C18 nano-trap column at a flowrate of 5 μl/min by an
Ultimate 3000 RS autosampler (Dionex, Camberley UK). The
composition of the loading solution was 0.1% formic acid and
acetonitrile (98:2). Once loaded onto the trap column the
sample was then washed off into an Acclaim PepMap C18
nano-column 75 μm × 15 cm, 2 μm 100 Å at a flowrate of
0.3 μl/min. The trap and nano-flow column were maintained
at 35 °C in a column oven in the Ultimate 3000 RSLC. The
samples were eluted with a gradient of solvent A: 0.1% formic
acid and acetonitrile (98:2) versus solvent B: 0.1% formic acid
and acetonitrile (20:80) starting at 5% B rising to 50% B over
100 min. The column was washed using 90% B before being
equilibrated prior to the next sample being loaded.
The eluant from the column was directed to a Proxeon
nano-spray ESI source (Thermo Fisher Hemel UK) operating in
positive ion mode then into an Orbitrap Velos FTMS. The
ionisation voltage was 2.5 kV and the capillary temperature
was 200 °C. The mass spectrometer was operated in MS–MS
mode scanning from 380 to 2000 amu. The top 20 multiply
charged ions were selected from each full scan for MS–MS
analysis, the fragmentation method was CID at 35% collision
energy. The ions were selected for MS2 using a data dependant
methodwith a repeat count of 1 and repeat and exclusion time
of 15 s. Precursor ions with a charge state of 1 were rejected.
The resolution of ions inMS1was 60,000 and 7500 for HCDMS2.
2.6. CE–MS data processing
Mass spectra were processed using MosaiquesVisu software
(Mosaiques Diagnostics, Hannover, Germany), including peak
picking, deconvolution and deisotoping [23]. The software
automatically examines all mass spectra from a CE–MS
analysis for signals above the threshold (SNR ^4). Only signals
that are present in 3 consecutive spectra are accepted. Next,
the isotopic distribution is assessed and charge is assigned
based on the isotopic distribution, using a matched filtering
algorithm. This operation results in a list wherein all signals
that could be interpreted are defined by mass/charge, charge,
migration time, and signal intensity (ion counts). This list is
transformed into a dataset containing only mass, migration
time, and signal intensity, signals that represent the same
compound but with a different charge state are combined. The
final result is a list of the compounds present in the sample
with their identity defined by mass, migration time and their
relative abundance defined by ion counts.
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to allow compilation and comparison of samples. Reference
signals of over 380 ‘milk housekeeping polypeptides’ were
used for CE-time calibration by local regression. The same
peptides were used for ion signal intensity normalization by
a applying a global linear regression. The resulting peak list
contained the molecular mass (Da) and normalized CE
migration time (min) for each feature. Normalized signal
intensity can be used as a measure of relative abundance.
Data sets were accepted only if they passed a strict quality
control criteria: A minimum of 950 chromatographic features
(mean number of features minus one standard deviation)
must be detected with a minimal MS resolution of 8000
(required resolution to resolve ion signals with z = 6) in a
minimal migration time interval (the time window, in which
separated signals can be detected) of 10 min. After calibration,
the mean deviation of migration time (compared to reference
standards) must be below 0.35 min.
Control and disease-specific polypeptide patterns were gen-
erated using support vector machine (SVM)-based MosaCluster
software Mosaiques Diagnostics (Hannover, Germany).
2.7. LC–MS/MS—data processing
Raw spectral data from LC–MS/MS analysis of the samples were
uploaded to Thermo Proteome Discoverer 1.2 Thermo Scientific
(Hemel Hempstead, UK). Peak picking was performed under
default settings for FTMS analysis such that only peptides with
signal to noise ratio higher than 1.5 and belonging to precursor
peptides between 700–8000 Da were considered. Peptide and
protein identification was performed with SEQUEST algorithm.
An in house compiled database containing proteins from the
latest version of the UniProt SwissProt database was compiled
to include only Bos taurus, E. coli and S. aureus entries. This
concatenated database was selected to facilitate peptide iden-
tification and reduce the probability for false positive identifica-
tions upon making searches against 3 differently sized FASTA
databases. No enzyme cleavage was selected and oxidation of
methionine and proline was chosen as variable modifications.
Precursor tolerance was set at 20 ppm and 0.1 Da for MS/MS
fragment ions. Resulting peptides and protein hits were further
screened by excluding peptides with an error tolerance higher
than 10 ppm and by accepting only those hits listed as high
confidence by Proteome Discoverer software. Theoretical
migration times in CE–MS for any resulting peptides were
calculated so that sequences obtained with LC-MS/MS could be
subsequently assigned to a position in the CE–MS analysis.Fig. 1 – Compiled CE–MS peptide fingerprints of the control
milk samples (n = 10) (A) and all mastitic milk samples
(n = 27) (B). On the X axis the CE migration time (min) is
plotted against the molecular mass (kDa) on the Y axis on a
logarithmic scale. The Z axis represents the mean signal
intensity.3. Results
3.1. Polypeptide fingerprinting for control and infected
groups
In each sample analysed we were able to detect >1000 differ-
ent peptides based on migration time and mass. The molec-
ular weight range of these peptides ranged from 0.8 to 20 kDa.
Data from individual CE–MS analysis was compiled according
to their group in order to develop biomarker patterns for the
different conditions studied.3.1.1. Healthy versus mastitis samples
Initially in this work we investigated whether differences
existed in the milk proteome of healthy cows (n = 10) when
compared to mastitic cows, regardless of their bacterial cause
(n = 27). The polypeptide fingerprints of these two groupswere
very different as shown in Fig. 1, with many of the multiply
charged highmolecular weight peptides being absent from the
infected group. A total of 508 peptides were significantly
different after correcting for multiple testing (BH < 0.05).
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Based on the data described above, multiple testing of sta-
tistical analysis was done to discriminate peaks between
control and infected groups. In the firstmodel, using a training
set of randomly selected controls (n = 5) and infected (n = 14)
samples we selected discriminatory peptides with a BH < 0.05
and with the area under curve (AUC) set at 1. Following these
very stringent conditions a group of 154 of the 508 peaks was
determined to be a potential biomarker panel that can be used
to discriminate between control and infected groups. Upon
using leave-one-out cross-validation of the training set for
verification an accuracy of 100%was observed. Thismodelwas
applied to a test set of controls (n = 5) and infected (n = 13)
with a sensitivity and specificity of 100%. Therefore, peptides
from this model could be used to discriminate between
non-infected and infected group with an accuracy of 100%
(Fig. 2).
3.1.3. E. coli infected versus S. aureus infected samples
The next step was to investigate the differences in milk pro-
teome of infected samples caused by the two different bac-
terial pathogens (E. coli versus S. aureus). The polypeptide
profiles of these 2 different groups did not differ as markedly
as is demonstrated in Fig. 3. A total of 47 peptides were sig-
nificantly different between both groups after correcting for
multiple testing (BH < 0.05). In this case the biomarker panel
was made up of all 47 discriminatory peptides.
3.1.4. Model generation of the polypeptide fingerprints
Based on the polypeptide fingerprints described above,
multiple testing of statistical analysis was done to discrimi-
nate peaks between two infected groups caused by E. coli and
S. aureus. A model was generated using a training set of
un-selected samples from E. coli (n = 11) and S. aureus (n = 8)
and a group of 47 peptides (significantly different peptides
after correcting for multiple testing) was determined to be a
biomarker panel that could discriminate between causative
bacteria. Upon cross-validation of the training set an accuracy
of 100% was obtained. This model was then tested in a test setFig. 2 – Box-and-whisker plots of the classification factor
obtained for the control (n = 5) vs. infected (n = 14) of the
training set and the test set in a blinded assessment of milk
samples from control (n = 5) and infected (n = 13) cows.
Fig. 3 – Compiled CE–MS peptide fingerprints of the milk
samples from quarters with mastitis caused by E. coli (n = 15)
(A) and S. aureus (n = 12) (B) infections. On the X axis the CE
migration time (min) is plotted against the molecular mass
(kDa) on the Y axis on a logarithmic scale. The Z axis
represents the mean signal intensity.of E. coli (n = 4) and S. aureus (n = 4). This model allowed a
correct classification of 4/4 E. coli and 3/4 S. aureus thus giving
a sensitivity on the limited test set of 75% while the specificity
was 100% (Fig. 4).
3.2. Peptide sequencing
In order to identify the discriminatory peptides of themodels by
their sequences, samples were analysed using LC–MS/MS. The
Fig. 4 – Box-and-whisker plots of the classification factor
obtained for the E. coli (n = 11) vs. S. aureus (n = 8) of the
training set and the test set in a blinded assessment of
infected milk samples from E. coli (n = 4) and S. aureus
(n = 4) samples.
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database which was compiled to include only Bos taurus, E. coli
and S. aureus entries. All identified peptides obtained with high
confidence from the LC–MS/MS analysis, that matched the
mass and migration time of a peptide in the CE–MS analysis
used in the models, are listed in Tables 1 and 2. In the model
classifying healthy versus infected samples 33 peptides were
identified out of 154 peptides (Table 1). On the other hand, from
the model used to classify samples from E. coli versus S. aureus
15peptideswere sequenced out of the 47 that formed themodel
(Table 2). The frequency of occurrence of each peptide is listed
in Tables 1 and 2 as well as their mean amplitude.
3.3. Protein identification
As described above, the protein identity was derived from
matching the amino acid sequences against a protein database.
The identified and named proteins are presented as in Tables 1
and 2. Combining both sets, peptides originating from twelve
proteins were identified with the majority of the originating
proteins being known milk protein such as αS1-casein and
β-casein.4. Discussion
The chosenpeptidomicmethod of capillary electrophoresis (CE)
coupled with the electrospray mass spectrometry is known
for its rapid (approximately 45 min per sample), sensitive and
automated approach [24]. The principle of separation in a CE
system ensures that all peptides present in the sample
will migrate through the capillary and pass into the detector in
a consistent solvent suitable for detection. This analytical
platform was used to detect quantitative differences in the
peptidome of milk between samples of milk from healthy cows
(control) and milk from infected udder quarters of cows with
mastitis caused by two different bacterial pathogens (E. coli and
S. aureus).All milk samples were analysed by CE–MS and only poly-
peptides present at a frequency >80% in at least one group
(control or cases) were chosen for analysis. The milk poly-
peptide patterns of infected cows were markedly different
from control cows. The milk polypeptide patterns when com-
paring the causative bacteria (E. coli and S. aureus) were more
similar but still had identifiable quantifiable differences.
There are only a very small number of studies in which
peptide analysis has been performed on bovine milk sam-
ples during mastitis [15,25]. Both studies employed the same
method, RP-HPLC, in separating the peptides, while further
protein characterization was performed by MALDI-TOF/MS/
MS. These studies focused on the result of proteolysis caused
by different types of proteolytic enzymes. Wedholm et al. [25]
successfully identified 10 peptides from milk with high SCC
(16 000 000 cells/ml). Larsen et al. [15] identified approximately
20 different peptides in milk samples from mammary glands
infused with LTA from S. aureus, with peptides resulting
from the action of endogenous proteases in response to the
LTA. The objective of these studies was to investigate milk
protease activity during mastitis. In contrast, the objective
of the present study was to determine how the peptide profile
of milk samples is altered in bovine mastitis. The CE–MS
methodology used in this study allows quantitative analysis of
all the peptides present in the samples. It has a number of
advantages in peptide analysis over the more popular meth-
odology of LC separation followed by MS or MS/MS identifica-
tion [26].
A secondary objective was to discover and characterize the
peptides that made up the biomarker in bovine mastitis.
However, due to the small sample loading capacity in CE it
is not possible to obtain MS/MS data to allow sequencing.
Sequencing was carried out using LC–MS/MS. LC separation of
peptides misses many of the most polar peptides and also the
larger more hydrophilic molecules and therefore many of the
peptides used to generate the biomarker panels have no
sequence data. However, we did see some overlap with the 14
peptide sequences described by Larsen et al. [15]. In Table 1 we
have no exact matches though peptide IDs 2367, 2719, 3223
and 3879 are smaller fragments of one of the peptides listed by
Larsen et al. [15]. In Table 2 there is one exact match with
another peptide described by Larsen, peptide ID 10468 and a
smaller fragment of this peptide ID 9569. As the majority of
peptides in the biomarkers are only seen in CE–MS and our
sequencing is by LC–MS/MS it is reassuring that there is some
overlap with the LC fractions identified by MALDI/MS/MS
analysis of Larsen et al. [15]. From the results it is clear that in
clinical mastitis themilk proteome, or more precisely themilk
peptidome as only peptides of <20 kDa were examined in this
study, increases in complexity with an increase in the number
and intensity of low MW peptides. The high sensitivity and
specificity of the differentiation of milk from healthy animals
compared to that from udder quarters suffering from mastitis
were an encouraging result in biomarker discovery for this
economically important disease. Furthermore the potential
for discrimination between the causative bacteria by peptide
analysis is an exciting development. Currently, such discrim-
ination would require time consuming bacterial identi-
fication. If a rapid method could be developed, following
validation of discrimination in future studies, there could be
Table 1 – Protein identities from peptides used in the model to differentiate healthy (control) versus infected (case) samples.
Model was composed of 154 peptides from which 33 were identified.
Peptide
ID
Peptide
mass
(Da)
CE
time
(min)
Sequence peptide Protein identity Freq
control
Freq
case
Mean
amplitude
control
Mean
amplitude
case
479 932.53 35.34 LIVTQTMK Major allergen
β-lactoglobulin
1.00 0.86 2.79 1.41
922 1019.58 35.96 EPVLGPVRGP β-casein 1.00 0.29 2.29 0.25
1299 1093.66 33.86 PVRGPFPIIV β-casein 1.00 0.29 1.62 0.10
2367 1275.67 32.18 PFPEVFGKEKV αS1-casein 0.60 1.00 0.51 3.50
2426 1286.70 30.80 QVWEESLKRL Lactoperoxidase 1.00 0.07 1.47 0.03
2644 1332.65 37.83 EMPFPKYPVEP β-casein – 1.00 – 1.98
2719 1346.72 31.92 VAPFPEVFGKEK αS1-casein 0.80 1.00 1.57 3.64
2757 1652.76 21.06 SKVKEAMAPKHK β-casein 0.20 1.00 0.23 2.28
3058 1406.71 38.68 LWYNMLVAEPR Signal transducer and
activator of transcription 1
1.00 – 1.24 –
3223 1445.79 32.44 VAPFPEVFGKEKV αS1-casein – 1.00 – 3.87
3864 1588.92 36.06 EPVLGPVRGPFPIIV β-casein 1.00 0.14 2.48 0.21
3879 1592.86 33.25 FVAPFPEVFGKEKV αS1-casein – 1.00 – 3.83
3882 1593.70 39.49 RSNVQSPDATEEDF Osteopontin 1.00 – 2.46 –
3913 1597.81 27.98 HKEMPFPKYPVEP β-casein – 1.00 – 3.01
4226 1667.90 40.05 LYQEPVLGPVRGPFP β-casein – 1.00 – 3.865
4394 1713.80 40.49 IPNPIGSENSEKTTMP αS1-casein 0.20 1.00 0.07 2.64
4639 1780.98 40.76 LYQEPVLGPVRGPFPI β-casein 0.40 1.00 0.46 3.95
4710 1799.03 29.26 YLGYLEQLLRLKKY αS1-casein – 1.00 – 3.00
5067 1894.08 41.47 LYQEPVLGPVRGPFPII β-casein 0.20 1.00 0.28 3.67
5385 1978.95 34.68 RAAPGPASAPSSGYREFVQ Interleukin 4-receptor – 1.00 – 1.77
5445 1997.06 26.69 GSKASADESLALGKPGKEPR Fibroblast growth
factor-binding protein
1 0.21 2.28 0.35
5482 2007.15 42.04 LLYQEPVLGPVRGPFPII β-casein 0.20 1.00 0.28 2.95
5594 2041.14 41.99 FLLYQEPVLGPVRGPFPI β-casein – 1.00 – 2.93
5904 2125.03 42.75 LQSQASRSTISSSFGNEETP Rho guanine nucleotide
exchange factor
0.20 1.00 0.42 3.84
6017 2153.17 24.36 RGSKASADESLALGKPGKEPR Fibroblast growth
factor-binding protein
1.00 0.64 2.55 0.71
6158 2190.06 32.31 HKEMPFPKYPVEPFTESQ β-casein – 1.00 – 2.28
6240 2215.05 43.51 SDIPNPIGSENSEKTTMPLW αS1-casein 1.00 1.00 1.85 4.28
6300 2231.06 43.73 SDIPNPIGSENSEKTTmPLW αS1-casein – 1.00 – 2.85
6465 2277.28 27.64 SSRQPQSQNPKLPLSILKEK Glycosylation-dependent
cell adhesion molecule
1.00 0.71 3.27 0.82
6961 2406.17 33.25 HKEMPFPKYPVEPFTESQSL β-casein – 1.00 – 2.44
7095 2440.39 24.84 SRQPQSQNPKLPLSILKEKHL Glycosylation-dependent
cell adhesion molecule
1.00 0.14 2.26 0.14
7454 2527.42 25.01 SSRQPQSQNPKLPLSILKEKHL Glycosylation-dependent
cell adhesion molecule
1.00 0.86 4.22 1.56
11162 3464.84 35.54 HLPLPLLQSWMHQPHQPLPPTVMFPPQSVL β-casein – 1.00 – 2.35
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Whether the differences in peptidome pattern are due directly
to bacterial action in breaking down largermilk proteins or are
due to differences in the host response to infection is not clear
but should be the objective of future investigation.
A total of 48 polypeptides were sequenced by LC–MS/MS
(Tables 1 & 2). These polypeptides were identified based on
their protein accession information and amino acid sequences
and were found to be fragments of larger and mostly known
milk proteins. The UniPortKB database was used to search
for each of the protein identities. The result of the database
search using the peptide sequence produced a list of proteins
including αS1-casein, β-casein, β-lactoglobin, lactoperoxidase,
osteopontin, interleukin 4-receptor, fibroblast growth factor
binding protein, glycosylation-dependent cell adhesion mole-
cule 1 (GlyCAM-1), rho guanine nucleotide exchange factor,signal transducer and activator of transcription 1 and tubulin
α-1C chain. One peptide produced two possible sequences
whichmatched bothmass andmigration time from theCE–MS
data. The proteins identified from these two potential se-
quences were β-casein and ANKRD9 protein. As we are inter-
ested in discriminatory polypeptides, the discussionwill focus
on the polypeptides and related proteins that were used to
discriminate between control, infected and two different
bacterial pathogen groups.
Statistically, peptides derived fromβ-lactoglobin,α S1-casein,
β-casein, lactoperoxidase, osteopontin, interleukin 4 receptor,
FGFBP and glyCAM 1 were the peptides that can be used to
discriminate the control from the infected groups.
During mastitis, the endogenous proteolytic activity in milk
increases substantially [15,27,28] and it is known that plasmin
can hydrolyse β-casein, αS2-casein and αS1-casein [29] which
Table 2 – Protein identities from peptides used in the model to differentiate E. coli versus S. aureus. Model was composed of
47 peptides from which 15 were identified.
Peptide
ID
Peptide
mass (Da)
CE time
(min)
Sequence peptide Protein
identity
Freq
E. coli
Freq
S. Aureus
Mean
amplitude
E. coli
Mean
amplitude
S. aureus
670 975.53 36.14 FPKYPVEP β-casein 1.00 0.67 1.62 0.64
3264 1454.77 27.56 SETGAGKHVPRAVF Tubulin α-1C chain 0.13 1.00 0.07 2.07
3488 1495.77 39.17 RELEELNVPGEIV β-casein 1.00 0.20 1.36 0.43
3869 1589.84 33.56 FLQPEVMGVSKVKE β-casein 0.50 1.00 0.56 2.17
4247 1673.86 39.47 VPYPQRDMPIQAFL β-casein 1.00 0.17 2.03 0.25
4582 1763 22.30 RPKHPIKHQGLPQEV αS1-casein 1.00 0.83 3.98 2.98
5593 2041.06 26.54 APKHKEMPFPKYPVEPF β-casein 0.25 0.83 0.47 1.43
7524 2546.30 26.50 EERLHSMKEGIHAQQKEPMIGV αS1-casein 1.00 0.17 2.57 0.31
8016 2656.44 26.04 KHPIKHQGLPQEVLNENLLRFF αS1-casein 1.00 0.33 2.47 0.41
8093 2676.48 34.40 SQSKVLPVPQKAVPYPQRDMPIQA β-casein 0.38 1.00 0.31 2.91
8639 2801.40 38.80 RELEELNVPGEIVESLSSSEESITR β-casein 1.00 0.50 2.23 0.93
9569 3005.65 36.49 LSLSQSKVLPVPQKAVPYPQRDMPIQA β-casein 1.00 0.67 2.36 1.00
9725 3044.48 31.21 KIEKFQSEEQQQTEDELQDKIHPFA β-casein 0.88 0.33 2.33 0.45
10468 3249.83 35.90 LSLSQSKVLPVPQKAVPYPQRDMPIQAFL β-casein 1.00 0.50 3.96 0.78
10479 3252.67 35.15 HLPLPLLQSWMHQPHQPLPPTVMFPPQS β-casein 0.88 0.50 2.66 0.86
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in milk from the infected group. The results presented here,
from investigation of naturally occurring mastitis, are in agree-
ment with investigations of experimental induction of mastitis
with LTA [15] or lipopolysaccharide [28] in which plasmin
activity in milk increased and casein derived peptides were
identified by reverse phase HPLC [15] or 2 dimension electro-
phoresis and mass spectroscopy [28] during mastitis. It is likely
that plasmin and other endogenous peptides are responsible
in part at least for the production of the peptides identified by
this investigation. As αS1-casein and β-casein are major milk
proteins [30,31] they constitute a principle substrate for milk
proteolysis resulting from the action of endogenousproteinases
such as plasmin [32]. Although proteolytic activity in milk is
known to increase as a result of mastitis, other factors such as
the stage of lactation and lactation number can also contribute
to increase in this proteolytic activity [33].
The presence of GlyCAM 1 protein in bovine milk has been
reported previously [11,34]. Smolenski et al. [11] have identi-
fied it as one of the minor milk protein that is present in all
peak lactation, colostrums, mastitic whey and the milk fat
globule membrane (MFGM) whilst Boehmer et al. [34] consid-
ered it to be a host defence protein. It was surprising to observe
this minor milk protein which acts in the host defence
mechanism to appear in the control group in higher frequency
compared with the infected group.
The fibroblast growth factor-binding protein (FGFBP) is a
secreted carrier protein that releases fibroblast growth factors
(FGFs) from the extracellular matrix storage and thus enhanc-
ing the FGF activity [35]. Kawakami et al. [36] concluded that
FGFBP may be tightly associated with lactoferrin in bovine
milk. Plath et al. [37] have successfully examined the expres-
sion and localization of FGFBP in the bovine mammary gland
and it may be important in the local regulation of the bovine
mammary gland.
Statistically, peptides from αS1-casein,β-casein and tubulin
α-1C chain protein were the peptides that can be used
to discriminate between the bacterial cause of the mastitis.β-casein derived peptides were assigned to discriminate
S. aureus from E. coli infected group. As discussed above, the
presence of mastitis can increase the proteolytic activity in
bovine milk and it was not surprising that these polypeptides
were the result from β-casein hydrolysis, but it is not clear
how a number of β-casein derived peptides can contribute to
differential identification of the bacterial cause while other
β-casein peptides are included in the group to differentiate
milk from mastitic from healthy udders. It was also not clear
if β-casein peptides alone can be applied to discriminate
S. aureus from E. coli infected milk samples.
Although several proteins were successfully identified
using the protein database based on their sequences, those
proteins cannot be used per se as potential markers for each
group. This study only sequenced peptides resulting from
specific fragments of proteins. The peptide identity provides
an insight into which milk proteins were subjected to prote-
olysis or played a role in the diseasemechanism. It is apparent
that specific peptides resulting from particular proteases of
the host or bacteria were of varying importance in contrib-
uting to the discriminatory algorithms. However, no ultimate
conclusion can be made based on the protein identity that
has been identified in each of the group as the group sizes are
relatively small. Further study of more extensive numbers
of samples, stage of disease (clinical and subclinical) and
causative bacteria is warranted to determine if these promis-
ing results are indicative of a viable approach to improve
the diagnosis of bovine mastitis. Eventual use of the panel of
peptide found here in differential diagnosis of mastitis could
have a significant impact on the health of dairy cows and
in control of this important disease [3] allowing more efficient
targeting of antibiotic use. It would also be interesting to
investigate the time-course of infection and determine the
earliest time that can be applied to diagnose an infected
cow based on the proposed polypeptide biomarker of bovine
mastitis. More information on peptide sequencing will also
lead to a better understanding of the pathophysiology of
bovine mastitis.
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